|
RANBP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.52260004604443E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62458935193399E-12 |
| Normal-vs-Stage2 |
1.01919999995204E-07 |
| Normal-vs-Stage3 |
4.24879997851235E-09 |
| Normal-vs-Stage4 |
1.72021000000022E-05 |
| Stage1-vs-Stage2 |
9.711800E-01 |
| Stage1-vs-Stage3 |
8.607000E-01 |
| Stage1-vs-Stage4 |
7.627400E-01 |
| Stage2-vs-Stage3 |
9.129800E-01 |
| Stage2-vs-Stage4 |
7.459200E-01 |
| Stage3-vs-Stage4 |
6.574200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.48889950052956E-10 |
| Normal-vs-AfricanAmerican |
3.07639469454557E-11 |
| Normal-vs-Asian |
1.282450E-03 |
| Caucasian-vs-AfricanAmerican |
4.314200E-01 |
| Caucasian-vs-Asian |
8.855200E-01 |
| AfricanAmerican-vs-Asian |
8.980800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.43490005935598E-10 |
| Normal-vs-Female |
6.93899999681946E-08 |
| Male-vs-Female |
6.05989999999945E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.01289995782616E-09 |
| Normal-vs-Extreme_Weight |
4.83300066633774E-11 |
| Normal-vs-Obese |
4.95979923798018E-11 |
| Normal-vs-Extreme_Obese |
2.08999999995463E-06 |
| Normal_Weight-vs-Extreme_Weight |
9.341700E-02 |
| Normal_Weight-vs-Obese |
6.482000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.333000E-01 |
| Extreme_Weight-vs-Obese |
5.762600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.964400E-01 |
| Obese-vs-Extreme_Obese |
1.672390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.848690E-04 |
| Normal-vs-Age(41-60Yrs) |
3.96319999040884E-09 |
| Normal-vs-Age(61-80Yrs) |
2.88870039000244E-10 |
| Normal-vs-Age(81-100Yrs) |
2.62449999954839E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.401200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.880100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.292000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.748300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.000970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.763200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.35130034834208E-10 |
| Normal-VS-Type2 PRCC |
1.06550324119326E-11 |
| Normal-VS-KIRP CIMP |
5.858500E-03 |
| Normal-VS-Unclassified PRCC |
1.12820000008895E-07 |
| Type1 PRCC-VS-Type2 PRCC |
3.501000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.166050E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.590790E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.526030E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.066800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.517400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.14279696816766E-11 |
| Normal-vs-N1 |
1.52208999999459E-05 |
| Normal-vs-N2 |
9.580300E-03 |
| N0-vs-N1 |
9.775100E-03 |
| N0-vs-N2 |
2.247200E-01 |
| N1-vs-N2 |
6.846400E-01 |
|
|
